Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

September 17, 2024 Bella Czajkowski, National Correspondent Views

Two drugmakers recently announced that they will refund 340B covered entities that purchased certain medications following adjustments to their ceiling [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski

Eli Lilly and Amgen Announce Refunds, Amgen Issues NDC Change

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Bella Czajkowski

Site Footer Live